PUBLISHER: The Business Research Company | PRODUCT CODE: 1942713
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942713
Diagnostic wearable medical devices are electronic devices worn on the body that continuously monitor health data to help detect and diagnose medical conditions. They track vital signs, identify abnormalities, and provide real-time insights that support early diagnosis and personalized treatment.
The main categories of diagnostic wearable medical devices include vital signs monitors, sleep and activity monitors, fetal and obstetric monitoring devices, neuro monitoring devices, and electrocardiogram monitors. Vital signs monitors track key health parameters such as heart rate, blood pressure, and oxygen saturation. These devices are widely used in hospitals and home settings to observe patient health conditions and identify critical changes in vital signs. The distribution channels include online platforms, pharmacies, and hypermarkets, and the applications include sports and fitness, remote patient monitoring, and home healthcare.
Tariffs are impacting the diagnostic wearable medical devices market by increasing the cost of imported sensors, electronics, and components used in wearable devices. Segments such as ECG monitors, neuro monitoring wearables, and fetal monitoring devices are particularly impacted, with regions like China and Southeast Asia facing higher import duties. This has led to increased product costs and slower adoption in price-sensitive markets. However, tariffs have also encouraged local manufacturing, innovation in sensor technologies, and investment in domestic production, which could strengthen regional supply chains.
The diagnostic wearable medical devices market research report is one of a series of new reports from The Business Research Company that provides diagnostic wearable medical devices market statistics, including diagnostic wearable medical devices industry global market size, regional shares, competitors with a diagnostic wearable medical devices market share, detailed diagnostic wearable medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic wearable medical devices industry. This diagnostic wearable medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The diagnostic wearable medical devices market size has grown rapidly in recent years. It will grow from $8.09 billion in 2025 to $9.18 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to limited availability of wearable medical devices, high cost of early devices, reliance on traditional monitoring methods, growing awareness of health and fitness tracking, limited integration with mobile apps.
The diagnostic wearable medical devices market size is expected to see rapid growth in the next few years. It will grow to $15.01 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to technological advancements in sensors and wearable electronics, rising demand for remote patient monitoring, growing adoption of home healthcare solutions, integration with ai and cloud platforms, expansion of wearable use in fetal and neuro monitoring. Major trends in the forecast period include rising adoption of remote patient monitoring, increasing use of wearables in sports and fitness, growth in home healthcare monitoring, integration with mobile health applications, enhanced focus on continuous and real-time health tracking.
The increasing prevalence of chronic diseases is anticipated to support the expansion of the diagnostic wearable medical devices market going forward. Chronic diseases are long-term health conditions that develop gradually, persist over extended periods, and often require continuous management. Their growing prevalence is influenced by aging populations, sedentary lifestyles, unhealthy diets, rising obesity rates, and increased exposure to risk factors such as smoking and excessive alcohol consumption. Diagnostic wearable medical devices are increasingly adopted to manage chronic conditions by monitoring vital signs and health metrics in real time, enabling better disease management by patients and healthcare providers. For example, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, approximately 194 million US adults, or 76.4%, reported having at least one chronic condition in 2023. As a result, the increasing prevalence of chronic diseases is reinforcing growth in the diagnostic wearable medical devices market.
Leading companies operating in the diagnostic wearable medical devices market are focused on developing innovative solutions, such as glucose monitoring systems, to improve accuracy, enhance user experience, and support the management of chronic conditions including diabetes. Glucose monitoring systems are medical devices that measure and track blood glucose levels, enabling individuals to manage diabetes using real-time data and actionable insights. For example, in February 2023, Dexcom Inc., a US-based manufacturer of continuous glucose monitoring systems, introduced the next-generation Dexcom G7 CGM System for Medicare beneficiaries. This system features a smaller and more discreet design, faster warm-up time, and an integrated sensor-transmitter unit that enhances usability and accuracy, achieving an overall mean absolute relative difference (MARD) of 8.2%. It also provides customizable alerts, extended wear duration, and integration with digital health platforms and diabetes management devices.
In January 2024, Boston Scientific, a US-based global medical technology company, announced an agreement to acquire Axonics, Inc. for an undisclosed amount. The primary objective of this acquisition is to strengthen Boston Scientific's urology portfolio by integrating Axonics' innovative devices for treating urinary and bowel dysfunction, particularly through sacral neuromodulation therapies. Axonics, Inc. is a US-based medical technology company.
Major companies operating in the diagnostic wearable medical devices market are Apple Inc., Google LLC, Samsung Electronics Co. Ltd., Huawei Technologies Co. Ltd., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Medtronic plc, Koninklijke Philips NV, GE Healthcare, OMRON Corporation, Garmin Ltd., Dragerwerk AG & Co. KGaA, Molex LLC, ResMed Inc., Dexcom Inc., Boyd Corporation, Masimo Corporation, AliveCor Inc., VitalConnect Inc., BTS Bioengineering Corp., Cleveland Medical Devices Inc., Meril Life Sciences Pvt. Ltd., Activinsights Ltd., Murata Vios Inc.
North America was the largest region in the diagnostic wearable medical devices market in 2025. The regions covered in the diagnostic wearable medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the diagnostic wearable medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The diagnostic wearable medical devices market consists of sales of fitness trackers, smartwatches, heart rate monitors, and blood glucose monitors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Diagnostic Wearable Medical Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses diagnostic wearable medical devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for diagnostic wearable medical devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diagnostic wearable medical devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.